No Data
No Data
Zhonghong Medical (300981.SZ): Plans to invest 15 million yuan to subscribe to the Guotai Junan M&A Fund.
On December 26, Glorious Horizon announced that Zhonghong Medical (300981.SZ) has been planning to further expand and optimize the company's investment structure to promote the sharing and integration of SSE Select Resources Industries Index. The company intends to use its own funds of 15 million yuan to subscribe to the partnership interest in Xiamen ITG Group Corp., Ltd. and GTJA Innovation M&A Private Equity Fund Partnership (Limited Partnership) (referred to as "GTJA M&A Fund", "Partnership", or "Fund") and sign the limited partnership agreement for Xiamen ITG Group Corp., Ltd. and GTJA Innovation M&A Private Equity Fund Partnership (Limited Partnership), thus becoming a limited partner of the partnership. Upon completion of this investment, the company will Hold in GTJA.
Zhonghong Pulin Medical Products Registration Details Updated
Zhonghong Medical (300981.SZ): The subsidiary Jiangxi Kelun Medical Instruments Manufacturing Co., Ltd. has completed the registration change for medical instruments.
On December 17, Gelonghui reported that Zhonghong Medical (300981.SZ) announced that its subsidiary Jiangxi Ke Lun Medical Instruments Manufacturing Co., Ltd. recently obtained the "Medical Instruments Change Registration (Filing) Document" issued by the Jiangxi Provincial Pharmaceutical Supervision Administration. The production address for the disposable nasal cannula is changed to "Yichun City, Yuanzhou District, Pharmaceutical Industrial Park, Jiangxi Province"; the production address for the disposable sterile care package is changed to "Yuanzhou District, Pharmaceutical Industrial Park, Yichun City"; the production address for the visual respiratory oxygen mask is changed to "Yichun City, Yuanzhou District, Pharmaceutical Industrial Park, Jiangxi Province"; the production location for the disposable nebulizer.
China Red Medical (300981.SZ): It plans to use no more than 1 billion yuan of idle funds for securities investment in 2025.
On December 9, Gelonghui reported that Zhonghong Medical (300981.SZ) announced that the company and its controlling subsidiaries plan to use no more than 1 billion RMB (including principal) of idle self-owned funds for securities investment. The investment scope includes IPO allotment or subscription, stock repurchase, bonds investment, and other investment activities recognized by the Shenzhen Stock Exchange. The investment period is valid from January 1, 2025 to December 31, 2025.
Products of Zhonghong Pulin Medical Products' Unit Selected for Bidding
Zhonghong Pulin Medical Products Co., Ltd.'s (SZSE:300981) Share Price Boosted 29% But Its Business Prospects Need A Lift Too
No Data